Evidence map›Paper›PMID 35129855›Full record

ArticlePediatric dermatology2022

Evolution of incidence of chilblain-like lesions in children during the first year of COVID-19 pandemic.

Marta Bascuas-Arribas, David Andina-Martinez, Juan Añon-Hidalgo, Jose Antonio Alonso-Cadenas, Angela Hernandez-Martin, Nuria Lamagrande-Casanova, Lucero Noguero-Morel, Ana Mateos-Mayo, Isabel Colmenero-Blanco, Antonio Torrelo

Open access · greenAbstract read
In one paragraph

Article in Pediatric dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Marta Bascuas-ArribasEmergency Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
David Andina-MartinezEmergency Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.ORCID https://orcid.org/0000-0002-3082-8832
Juan Añon-HidalgoEmergency Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Jose Antonio Alonso-CadenasEmergency Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.ORCID https://orcid.org/0000-0002-7648-1336
Angela Hernandez-MartinDepartment of Dermatology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Nuria Lamagrande-CasanovaEmergency Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Lucero Noguero-MorelDepartment of Dermatology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.ORCID https://orcid.org/0000-0001-5694-8536
Ana Mateos-MayoDepartment of Dermatology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.ORCID https://orcid.org/0000-0001-9507-005X
Isabel Colmenero-BlancoDepartment of Pathology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Antonio TorreloDepartment of Dermatology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.ORCID https://orcid.org/0000-0002-5940-6916
Hospital Infantil Universitario Niño Jesús · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic has brought innumerable reports of chilblains. The relation between pernio-like acral eruptions and COVID-19 has not been fully elucidated because most reported cases have occurred in patients with negative microbiological tests for SARS-CoV-2.

methodsA retrospective study of 49 cases of chilblains seen during the first year of the pandemic in a children's hospital in Madrid, Spain. The incidence of these skin lesions was correlated with the number of COVID-19 admissions and environmental temperatures. Patients were separated into two groups depending on the day of onset (strict lockdown period vs. outside the lockdown period).

resultsMost chilblains cases presented during the first and third waves of the pandemic, paralleling the number of COVID-19 admissions. The first wave coincided with a strict lockdown, and the third wave coincided with the lowest ambient seasonal temperatures of the year. Systemic symptoms preceding chilblains were more frequent in the first wave (45.8% vs. 8.0%, p = .002), as was the co-occurrence with erythema multiforme-like lesions (16.7% vs. 0%, p = .033). Laboratory test and skin biopsies were performed more frequently in the first wave (75.0% vs. 12.0%, p < .001; and 25.0% vs. 0%, p = .007; respectively). Five patients developed recurrent cutaneous symptoms.

conclusionsAn increased incidence of chilblains coincided not only with the two major waves of the pandemic, but also with the strict lockdown period in the first wave and low seasonal temperatures during the third wave. Both increased sedentary behaviors and cold environmental temperatures may have played an additive role in the development of COVID-19-related chilblains.

Indexed as

ChilblainsCOVID-19Skin DiseasesChildCommunicable Disease ControlHumansIncidencePandemicsRetrospective StudiesSARS-CoV-2chilblainCOVID-19pediatric dermatologypernioSARS-CoV-2

Identifiers

PMID35129855
PMCPMC9115329
OpenAlexW4210826051

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.